PAS
MRNA icon

Point72 Asia (Singapore)’s Moderna MRNA Stock Holding History

Point72 Asia (Singapore)’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$44.3K Sell
1,716
-1,185
-41% -$33.1K 0.01% 583
2025
Q2 		$80K Buy
+2,901
New +$76.4K 0.01% 513
2025
Q1 		– Sell
-22,506
Closed -$936K – 1083
2024
Q4 		$936K Buy
+22,506
New +$1.08M 0.25% 96

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Point72 Asia (Singapore)'s MRNA Position: Q3 2025 in Review

Point72 Asia (Singapore) reduced its Moderna (MRNA) stake by 41% in Q3 2025, selling an estimated $33.1K and leaving 1,716 shares worth $44.3K. The position accounts for 0.01% of the portfolio, ranked #583.

Point72 Asia (Singapore) first reported a position in MRNA in Q4 2024 and has held it in 3 quarters since. The position peaked at $936K in Q4 2024. 643 funds tracked by Wall St. Rank hold MRNA as of Q3 2025.

  • Point72 Asia (Singapore) held 1,716 shares of Moderna worth $44.3K as of Q3 2025.
  • Point72 Asia (Singapore) sold 1,185 Moderna shares in Q3 2025, an estimated $33.1K.
  • Moderna made up 0.01% of Point72 Asia (Singapore)'s portfolio in Q3 2025, its #583 holding.
  • Point72 Asia (Singapore) first reported a position in Moderna in Q4 2024 and has held it in 3 quarters since.
  • Point72 Asia (Singapore)'s Moderna position peaked at $936K in Q4 2024.
  • 643 funds tracked by Wall St. Rank held Moderna as of Q3 2025.

Based on Point72 Asia (Singapore)'s 13F filing for Q3 2025, filed 14 Nov 2025.